Boster Biological Technology

Anti-PCNA Antibody

#BM0104 · western blot

29
Citing papers
620
Combined citations
Supplier page Find this product

Research areas

Mesenchymal stem cell research4Cancer-related molecular mechanisms research4Cancer Immunotherapy and Biomarkers3Cell Adhesion Molecules Research2Cancer-related Molecular Pathways2Cardiovascular, Neuropeptides, and Oxidative Stress Research2Cancer, Hypoxia, and Metabolism2Animal Virus Infections Studies2

Papers citing this product

1
Combination of oral STING agonist MSA-2 and anti-TGF-β/PD-L1 bispecific antibody YM101: a novel immune cocktail therapy for non-inflamed tumors
Journal of Hematology & Oncology·2022·178 cit.·DOI
2
Nucleocapsid Interacts with NPM1 and Protects it from Proteolytic Cleavage, Enhancing Cell Survival, and is Involved in PEDV Growth
Scientific Reports·2017·55 cit.·DOI
3
CC Chemokine Ligand 18 Correlates with Malignant Progression of Prostate Cancer
BioMed Research International·2014·47 cit.·DOI
4
Ubiquitinated AIF is a major mediator of hypoxia-induced mitochondrial dysfunction and pulmonary artery smooth muscle cell proliferation
Cell & Bioscience·2022·40 cit.·DOI
5
Differential expression of decorin, EGFR and cyclin D1 during mammary gland carcinogenesis in TA2 mice with spontaneous breast cancer
Journal of Experimental & Clinical Cancer Research·2010·34 cit.·DOI
6
Hsa_circ_0137008 suppresses the malignant phenotype in colorectal cancer by acting as a microRNA-338-5p sponge
Cancer Cell International·2020·32 cit.·DOI
7
STING agonist inflames the cervical cancer immune microenvironment and overcomes anti-PD-1 therapy resistance
Frontiers in Immunology·2024·31 cit.·DOI
8
HOXA5 inhibits the proliferation of extrahepatic cholangiocarcinoma cells by enhancing MXD1 expression and activating the p53 pathway
Cell Death and Disease·2022·31 cit.·DOI
9
Transplanted bone marrow stem cells relocate to infarct penumbra and co-express endogenous proliferative and immature neuronal markers in a mouse model of ischemic cerebral stroke
BMC Neuroscience·2010·23 cit.·DOI
10
A randomized, controlled clinical trial of autologous stromal vascular fraction cells transplantation to promote mechanical stretch-induced skin regeneration
Stem Cell Research & Therapy·2021·20 cit.·DOI

Similar products

ProductVendorPricePapers
PCNA (D3H8P) Rabbit Monoclonal AntibodyRabbitCell Signaling Technology$181100
PCNA (PC10) Mouse Monoclonal AntibodyMouseCell Signaling Technology$148100
PCNA (PC10) Mouse Monoclonal Antibody (Alexa Fluor® 488 Conjugate)MouseCell Signaling Technology$465100
PCNA (PC10) Mouse Monoclonal Antibody (SignalFlex™ Alexa Fluor® 750 Conjugate)MouseCell Signaling Technology$45824
Anti-PCNA antibody produced in rabbitrabbitSigma-Aldrich—8
PCNA (D3H8P) Rabbit Monoclonal Antibody (Alexa Fluor® 647 Conjugate)RabbitCell Signaling Technology$4658
PCNA (D3H8P) Rabbit Monoclonal Antibody (PE Conjugate)RabbitCell Signaling Technology$4653
PCNA (PC10) Mouse Monoclonal Antibody (SignalFlex™ Alexa Fluor® 647 Conjugate)MouseCell Signaling Technology$4582
PCNA (PC10) Mouse Monoclonal Antibody (BSA and Azide Free)MouseCell Signaling Technology$8651
PCNA (D3H8P) Rabbit Monoclonal Antibody (BSA and Azide Free)RabbitCell Signaling Technology$8651
Anti-PCNA Antibody — Evidence — PubIndex